No industry likes the kind of attention that medtech has been getting lately.

There are front page stories in national publications that speak disparagingly of new device models and updates as only offering “dubious improvement.” They allege that much of medtech innovation amounts to “planned obsolescence.”

James Varelis, Principal, PwC Health Industries

At its core, the claim is that device...

April 24th, 2014
0

Conflicting reports have emerged following a CNET report that Nike has laid off a number of its engineering team associated with the Fuelband.

When news initially broke, rumors stated that the company would be exiting the wearables market and shuttering its Fuelband product. It also sparked speculation in publications like Wired that this move was due to Nike's buddy-buddy relationship with Apple and that the sports brand was politely stepping aside to make room for Apple's iWatch – which as of now still remains the mythical unicorn of wearable technology.
 
...
April 23rd, 2014
3

Jose Delgado Jr. a 53-year old man who was born without a left hand, has a new prosthesis option thanks to E-Nable, an online volunteer group dedicated to creating and providing inexpensive assistive technologies using 3-D printing.

The group created a 3-D printed mechanical hand, dubbed the Cyborg Beast, for Delgado and asked him to relay his experience with it as compared to his $42,000 myoelectric prosthesis.
 
 
The ...
April 22nd, 2014
0

A federal appeals court granted Medtronic a temporary stay on an injunction that would have prevented the device maker from selling its CoreValve Transcatheter Aortic Valve Replacement system in the U.S.

Some analysts have said that injunctions being issued in the U.S. preventing sale of products are a rare phenomenon. While it has a temporary reprieve, Medtronic now has to convince the Federal Circuit Court of Appeals that its products do not infringe upon the patent of rival Edwards Lifesciences and that the injunction was improperly issued. How does this legal case affect patients.

The Minnesota company only has a few months to persuade the court that the injunction was improperly issued. By Medtronic’s own...

April 22nd, 2014
0

As a medtech firm, getting venture capitalists to invest in a seed stage of financing is akin to trying to get water out of stone.

However, exceptions prove the rule, and so here are three companies that managed the impossible in the first quarter of 2014 in order of most money raised. The information comes from the PricewaterhouseCoopers LLP (PwC) and the National Venture Capital Association (NVCA), based on data provided by Thomson Reuters.

Drum roll please…

scPharmaceuticals
Despite their name, scPharmaceuticals is not really a typical pharma company interesting in developing novel formulations to treat diseases via oral, injectable or intravenous means. Rather this Lexington, Massachusetts-based company has a novel drug delivery...

April 18th, 2014
0

What don't medical device makers do because they have figured out how to get away with not doing it?

By William A. Hyman

 

Back in the ancient days of 2006, I wrote a commentary in MD+DI entitled “What Wouldn’t You Do If FDA Didn’t Make You?” That piece arose from the multiple times I had heard medical device professionals and researchers suggest that they would take a faster (i.e., riskier) course if not for FDA stopping them or, perhaps, catching them.

Learn how to avoid regulatory pitfalls with early clinical involvement at ...
April 17th, 2014
0

If the concept of wearable technology has lately entered your consiciousness and you believe that it is a 21st Century phenomenon, you would be dead wrong.

In fact the infographic below, presented by Vandrico Inc., traces the first instance of wearable technology back to 1644 when the Qing Dynasty miniaturized the abacus and put it in a ring. Even back then, they got it right about what constitutes a true wearable - it needs to be controlled by the user/consumer.

Learn more about the new era of consumerization and usability at the MD&M East Conference and Expo, June 9, New York City. 

The abacus-in-a-ring was wearable technologies'...

April 17th, 2014
0

MD&M Texas will be hosting Learning Labs aimed at informing and inspiring attendees about the latest trends and technologies that are impacting medical manufacturing and technology.

The conference and trade show takes place May 7–8, 2014, in Fort Worth, TX.

Here are some of the hot topics that will be covered at the conference.
 
...
April 4th, 2014
0

 

Managing heart failure patients has become such a priority at hospitals that even device companies like Medtronic have jumped into the fray.

Medtronic bought a telemedicine company last year to help monitor these chronic patients from afar thereby helping hospitals not incur penalties from these same heart failure patients getting readmitted to the hospital within 90 days of discharge.

Other hospitals are looking at heart failure management in different ways. At Cedars-Sinai in Los Angeles , for example, physicians have created a heart failure management program that uses handheld ultrasounds instead of the humble stethoscope and reviews biomarkers of these patients to reduce readmission rates.

Mayo Clinic, however, appears to believe that there’s an app for heart failure management.

The venerable institution recently announced results of a small study at the American College of Cardiology meeting in Washington, D.C. that showed that...

April 3rd, 2014
0

 

Managing heart failure patients has become such a priority at hospitals that even device companies like Medtronic have jumped into the fray.

Medtronic bought a telemedicine company last year to help monitor these chronic patients from afar thereby helping hospitals not incur penalties from these same heart failure patients getting readmitted to the hospital within 90 days of discharge.

Other hospitals are looking at heart failure management in different ways. At Cedars-Sinai in Los Angeles, for example, physicians have created a heart failure management program that uses handheld ultrasounds instead of the humble stethoscope and reviews biomarkers of these patients to reduce readmission rates.

Mayo Clinic,...

April 3rd, 2014
0